Skip to content

Physiotherapy for Urinary Incontinence resulting from treatment of Cervical Cancer

Physiotherapy in Urinary Incontinence resulting from the treatment of Cervical Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9s356k
Enrollment
Unknown
Registered
2018-05-16
Start date
2017-08-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary incontinence

Interventions

Initially, 20 volunteers who underwent cancer of the cervix treatment will be evaluated in the first session, through the functional kinesiological evaluation of urinary incontinence and the applicati
Other
H02.010.625
E02.331
E02.190.599.750.750
G11.427.410.698.277

Sponsors

Universidade do Estado do Pará
Lead Sponsor
Hospital Ophir Loyola
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women aged between 25 and 65 will be included in the survey; who have had treatment for cervical cancer; that show Karnofsky Performance Status above 70%; who have stopped treatment for cervical cancer for a maximum of one year and at least one month; who present with urinary incontinence; the participants must present conditions of full control so that they have the autonomy to sign the informed consent form

Exclusion criteria

Exclusion criteria: Women residing in the interior of the State of Pará will be excluded from the survey; that present metastases; who have other pathologies associated as neurological problems; cardiac disorders; respiratory and diabetes mellitus; metal plates; pacemaker; who already had urinary incontinence prior to treatment for cervical cancer and local infection

Design outcomes

Primary

MeasureTime frame
1) Strength and endurance is observed by the kinesiological evaluation of the pelvic floor muscles;The tone of the muscles of the pelvic floor is observed by the bigidital touch;;3) The involuntary loss of urine and reduction of voiding urgency is observed by the PRAFAB questionnaire;4) The urinary frequency is observed by the International consultation on incontinence questionnaire overactive bladder;5) Quality of life is observed by the International consultation on incontinence questionnaire - short form and King's health questionnaire

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactErica Carneiro Nunes

Universidade do Estado do Pará

ericacarneiro@uepa.br+55-091-982073336

Outcome results

None listed

Source: REBEC (via WHO ICTRP)